ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Santhera Pharmaceuticals Holdings Ltd (PK)

Santhera Pharmaceuticals Holdings Ltd (PK) (SPHDF)

11.70
0.00
(0.00%)
Closed June 01 4:00PM

Professional-Grade Tools, for Individual Investors.

SPHDF News

Official News Only

SPHDF Discussion

View Posts
Renee Renee 11 months ago
SPHDF one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
beebob77 beebob77 10 years ago
SPHDF is one step ahead in DMD submission!

Check out Santhera Pharm with a 100 - 400% opportunity:
In comparision to the peers PTC or SRPT we have a fair value of 180USD/share without NDA submission.

Expected Upcoming Milestones
Q4 2014 – Start Phase I CALLISTO study for omigapil in CMD.
H1 2015 – CHMP decision on Raxone as an LHON treatment.
H1 2015 – NDA and MAA submission for Raxone/Catena as a DMD treatment.
H1 2015 – NDA submission for Raxone/Catena for LHON.
H2 2015 – Commercial launch of Raxone for LHON in EU.
Q1 2016 – Commercial launch of Raxone/Catena for DMD in US and EU.
H1 2016 – Commercial launch of Raxone/Catena for LHON in US.


DMD - Market Opportunity
The various price points are, on average, between $300,000 and $500,000 per patient per year. If you consider this in terms of the target population, the company estimates there would be about 2,000 patients in the U.S. that would be amenable to Eteplirsen. This translates into a $600 million to $1 billion market opportunity in the U.S. alone. The EU could add 9,000 additional patients as well.

LifeSci Capital Coverage: link

ValualationLAB Analysis: link
👍️0
stocktrademan stocktrademan 10 years ago
$SPHDF recent news/filings

bullish

## source: finance.yahoo.com

Fri, 15 Aug 2014 05:15:00 GMT ~ Santhera Receives CHF 13.4 Million Through Sale of Treasury Shares

[GlobeNewswire] - LIESTAL, Switzerland -- Santhera Pharmaceuticals (SIX:SANN) today announced that it completed the sale of 200,000 registered shares of common stock at an average price of CHF 66.85 per share, a 4.3% premium ...

read full: http://finance.yahoo.com/news/santhera-receives-chf-13-4-051500317.html
*********************************************************


$SPHDF charts



basic chart ## source: eoddata.com



$SPHDF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SPHDF/company-info
Ticker: $SPHDF
OTC Market Place: OTC Pink Current
CIK code: not found
Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com
Incorporated In: Switzerland


$SPHDF share structure

## source: otcmarkets.com

Market Value: $255,314,992 a/o Aug 18, 2014
Shares Outstanding: 3,660,430 a/o Aug 29, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$SPHDF extra dd links

Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SPHDF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SPHDF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SPHDF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/news - http://finance.yahoo.com/q/h?s=SPHDF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SPHDF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SPHDF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SPHDF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Santhera+Pharmaceuticals+Holdings+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Santhera+Pharmaceuticals+Holdings+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Santhera+Pharmaceuticals+Holdings+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.santhera.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.santhera.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.santhera.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SPHDF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SPHDF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SPHDF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SPHDF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SPHDF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SPHDF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SPHDF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SPHDF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SPHDF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SPHDF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SPHDF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SPHDF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SPHDF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SPHDF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SPHDF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SPHDF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SPHDF



$SPHDF DD Notes ~ http://www.ddnotesmaker.com/SPHDF
👍️0

Your Recent History

Delayed Upgrade Clock